BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29725448)

  • 1. Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1.
    Suzuki Y; Oshima T; Yoshihara K; Sakamaki K; Aoyama T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
    Oncol Lett; 2018 May; 15(5):7335-7343. PubMed ID: 29725448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.
    Numata K; Oshima T; Sakamaki K; Yoshihara K; Aoyama T; Hayashi T; Yamada T; Sato T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Kunisaki C; Akaike M; Imada T; Masuda M
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):415-22. PubMed ID: 26337161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.
    Higuchi A; Oshima T; Yoshihara K; Sakamaki K; Aoyama T; Suganuma N; Yamamoto N; Sato T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Kunisaki C; Imada T; Masuda M
    Oncol Lett; 2017 Feb; 13(2):905-911. PubMed ID: 28356977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of
    Katayama Y; Oshima T; Sakamaki K; Aoyama T; Sato T; Masudo K; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
    In Vivo; 2017; 31(4):565-571. PubMed ID: 28652421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
    Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S
    Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer.
    Nakajima M; Yoshino S; Kanekiyo S; Maeda N; Sakamoto K; Tsunedomi R; Suzuki N; Takeda S; Yamamoto S; Hazama S; Hoshii Y; Oga A; Itoh H; Ueno T; Nagano H
    Oncol Lett; 2018 Jan; 15(1):803-812. PubMed ID: 29403557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of SPARC gene expression in patients with gastric cancer.
    Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M
    J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.
    Maezawa Y; Sakamaki K; Oue N; Kimura Y; Hashimoto I; Hara K; Kano K; Aoyama T; Hiroshima Y; Yamada T; Yamamoto N; Ogata T; Ito H; Cho H; Shiozawa M; Yoshikawa T; Morinaga S; Rino Y; Yasui W; Masuda M; Miyagi Y; Oshima T
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):75-86. PubMed ID: 31754833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
    Gong L; Mao W; Chen Q; Jiang Y; Fan Y
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARC is associated with gastric cancer progression and poor survival of patients.
    Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
    Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Tensin 4 Gene Expression in Patients with Gastric Cancer.
    Sawazaki S; Oshima T; Sakamaki K; Aoyama T; Sato T; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
    In Vivo; 2017; 31(6):1065-1071. PubMed ID: 29102927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of FGFR2 expression in stage II/III gastric cancer with curative resection and S-1 chemotherapy.
    Hosoda K; Yamashita K; Ushiku H; Ema A; Moriya H; Mieno H; Washio M; Watanabe M
    Oncol Lett; 2018 Feb; 15(2):1853-1860. PubMed ID: 29434882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of SPARC expression after chemotherapy in gastric cancer.
    Gao YY; Han RB; Wang X; Ge SH; Li HL; Deng T; Liu R; Bai M; Zhou LK; Zhang XY; Ba Y; Huang DZ
    Cancer Biol Med; 2015 Mar; 12(1):33-40. PubMed ID: 25859409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
    Liu X; Zhang D; Lin E; Chen Y; Li W; Chen Y; Sun X; Zhou Z
    BMC Cancer; 2018 Jun; 18(1):699. PubMed ID: 29954375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
    Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.
    Davis EJ; Zhao L; Lucas DR; Schuetze SM; Baker LH; Zalupski MM; Thomas D; Chugh R
    BMC Cancer; 2016 Aug; 16():663. PubMed ID: 27544129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of secreted protein acidic in hematogenous metastasis of gastric cancer.
    Mo A; Yang SW; Jiang YX; Zhao YL; Shi Y; Qian F; Hao YX; Yu PW
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4311-4321. PubMed ID: 29077165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy.
    Nakazawa Y; Nakazawa S; Kurozumi S; Ogino M; Koibuchi Y; Odawara H; Oyama T; Horiguchi J; Fujii T; Shirabe K
    Oncol Lett; 2020 Apr; 19(4):2705-2712. PubMed ID: 32218821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection.
    Murakawa M; Aoyama T; Miyagi Y; Kobayashi S; Ueno M; Morimoto M; Numata M; Yamamoto N; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
    J Cancer; 2019; 10(3):627-633. PubMed ID: 30719160
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression and significance of secreted protein acidic and rich in cysteine in human osteosarcoma.
    Yang Y; Niu X; Liu W; Xu H
    Oncol Lett; 2017 Nov; 14(5):5491-5496. PubMed ID: 29142603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.